History

Axcan Pharma, a leading specialty pharmaceutical company in the field of gastroenterology, was established in 1982 by former Chairman of the Board, Léon F. Gosselin. Since its inception, Axcan has focused on a single specialization on which to build its reputation - gastroenterology. This singular focus has allowed the Company to leverage its resources hence maximizing its effectiveness in building enduring relationships with health authorities and medical practitioners around the globe.

The Company's principal activities of marketing gastroenterology-related pharmaceutical products and services are geared towards the treatment of symptoms in a number of gastrointestinal diseases and disorders, such as inflammatory bowel disease, cholestatic liver diseases, irritable bowel syndrome, and complications related to pancreatic insufficiency. During its history, Axcan has actively targeted and acquired products and companies in North America and Europe, and primarily focuses its operations within these geographic regions.

All activities underscore the Company’s single, well-defined Mission, which is to improve the quality of care and health of patients suffering from gastrointestinal diseases and disorders by providing effective therapies for patients and specialized caregivers.